EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Could positive allosteric modulators of the cannabinoid CB1 receptor be efficacious and safe for the treatment of chronic pain?

Hayley M Green, Michelle Glass

Current Opinion in Pharmacology · 2024

DOI: 10.1016/j.coph.2024.102495 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Opinion in Pharmacology, 2024. Verfasst von Hayley M Green und 1 weiteren Autor:innen. Beteiligte Einrichtung: The Herbert Wertheim University of Florida Scripps Institute for Biomedical Research and Innovation, 130 Scripps Way, Jupiter, FL, United States; Dep…. Hauptthemen laut MEDLINE: Receptor, Cannabinoid, CB1, Chronic Pain. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Royal Society of New Zealand Marsden Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cannabinoids are effective analgesics but induce adverse cannabimimetic effects and the development of tolerance. Allosteric ligands of the cannabinoid CB1 receptor (CB1) may harness the pain-relieving effects of cannabinoids with reduced adverse effects. CB1 allosteric ligands bind at a site topographically distinct from the orthosteric binding site. CB1 allosteric ligands have been shown to be effective pain-relieving drugs that do not appear to result in the production of adverse effects or the development of tolerance. While this therapeutic profile indicates that CB1 allosteric ligands could be an effective treatment for chronic pain, their molecular mechanism of action remains unclear.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, Cannabinoid, CB1Chronic PainHumansAnimalsAllosteric RegulationAnalgesicsCannabinoidsLigands

Substanzen

Receptor, Cannabinoid, CB1AnalgesicsCannabinoidsLigands

Autor:innen und Institutionen

  • The Herbert Wertheim University of Florida Scripps Institute for Biomedical Research and Innovation, 130 Scripps Way, Jupiter, FL, United States; Department of Pharmacology and Toxicology, University of Otago, Dunedin,…
  • Department of Pharmacology and Toxicology, University of Otago, Dunedin, Otago, New Zealand. Electronic address: michelle.glass@otago.ac.nz.

Förderung

  • Royal Society of New Zealand Marsden Fund

Zitieren

APA

Green, H. M., & Glass, M. (2024). Could positive allosteric modulators of the cannabinoid CB1 receptor be efficacious and safe for the treatment of chronic pain?. Current Opinion in Pharmacology. https://doi.org/10.1016/j.coph.2024.102495

Vancouver

Green HM, Glass M. Could positive allosteric modulators of the cannabinoid CB1 receptor be efficacious and safe for the treatment of chronic pain?. Current Opinion in Pharmacology. 2024. doi:10.1016/j.coph.2024.102495

BibTeX
@article{Green2024,
  author = {Green, Hayley M and Glass, Michelle},
  title = {Could positive allosteric modulators of the cannabinoid CB1 receptor be efficacious and safe for the treatment of chronic pain?},
  journal = {Current Opinion in Pharmacology},
  year = {2024},
  doi = {10.1016/j.coph.2024.102495}
}
Kostenlos starten →